Accelerate Diagnostics Inc ROCE
Quel est le ROCE de Accelerate Diagnostics Inc?
Le ROCE de Accelerate Diagnostics Inc est -294.47%
Quelle est la définition de ROCE?
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE des entreprises dans Health Care secteur sur NASDAQ par rapport à Accelerate Diagnostics Inc
Que fait Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Entreprises avec roce similaire à Accelerate Diagnostics Inc
- Anchiano Therapeutics Ltd a ROCE de -305.12%
- GetBack S.A a ROCE de -300.03%
- Phunware Inc a ROCE de -299.88%
- Avidian Gold a ROCE de -299.09%
- Sonnet BioTherapeutics Inc a ROCE de -297.19%
- Aziyo Biologics a ROCE de -295.71%
- Accelerate Diagnostics Inc a ROCE de -294.47%
- Exicure a ROCE de -292.22%
- Exicure a ROCE de -292.22%
- Exicure a ROCE de -292.22%
- Exicure a ROCE de -292.22%
- Portage Biotech a ROCE de -287.54%
- Adial Pharmaceuticals a ROCE de -286.20%